Related Experiment Video
Updated: Mar 31, 2026
16:05
Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
Published on: October 1, 2007
8.1K
Structural determinants of effective academic-industry technology transfer in biomedical engineering
Jolanta Pauk1, Konrad Pauk2, Anna Stec3
1Biomedical Engineering, Bialystok University of Technology, Bialystok, Poland.
Summary
Academia and industry collaboration in biomedical engineering faces challenges in daily operations. Successful partnerships require clear communication, joint intellectual property frameworks, and early stakeholder involvement for effective technology transfer.
Area of Science:
- Biomedical Engineering
- Technology Transfer
- Innovation Management
Background:
- Macro-level factors in academia-industry collaboration are known, but daily operational processes, especially in complex biomedical engineering, remain under-explored.
- Understanding decision-making, governance, and coordination is crucial for improving technology transfer and innovation outcomes in this field.
Purpose of the Study:
- To analyze the decision-making, governance, and coordination practices in university-industry collaborations within biomedical engineering.
- To identify barriers and facilitators for effective technology transfer and innovation.
Main Methods:
- Employed a mixed-methods approach combining structured questionnaires with academic and industrial stakeholders.
- Conducted detailed case studies to illustrate practical examples of collaboration in biomedical technology transfer.
Main Results:
- Academia prioritizes new technologies and societal impact, while industry focuses on market implementation and competitiveness, revealing diverging motivations.
- Key barriers include time constraints, publication vs. confidentiality conflicts, and intellectual property (IP) negotiation difficulties.
- Facilitators include long-term funding, administrative support, hybrid work models, clear regulatory frameworks, and mutual objective understanding.
Conclusions:
- Future university-industry partnerships must establish clear communication, joint IP frameworks, and inclusive governance from inception.
- Early engagement of clinical practitioners and end-users enhances product relevance.
- Proactive regulatory planning and institutional support are vital to prevent delays and ensure compliance.
Related Concept Videos
01:22Bioreactor Controls-III
51
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
51
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
447
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
447
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
533
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
533
01:30Production of Pharmaceuticals
52
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
52
01:59Plant Breeding and Biotechnology
22.3K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
22.3K
01:29Bioreactor Design and Operational System
72
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
72